Microbiome

[ARTICLE] Microbiome Analysis: 16S Metabarcoding or Shotgun Metagenomics?

To date, Next Generation Sequencing (NGS) techniques remain the most commonly used methodologies for studying the microbiome, a major subject of scientific research in recent years. Among the thousands of articles published each year (illustration 1), two main...

[ARTICLE] Skin-to-skin contact: an effective anti-stress strategy that also favourably impacts the gut microbiota

Birth is an intensely stressful event for both the baby and the mother. Stress hormones help the baby adapt to the new, cold, dry, and oxygen-rich environment outside the womb. However, excessive stress can be harmful. Fortunately, the body has anti-stress mechanisms...

Make clinical data reviews more efficient with the interactive visualisation of Patient Profiles

From context to implementation of idea An important step in any clinical trial is the blind data review. This process takes place between the end of the study (when the data are collected, input, and validated) and the breaking of the blind and final data lock, after...

How does our platform AnonyMine solve the problem of Data Anonymisation?

Would you like to reuse data for other studies, communicate on internal research, or just publish sensitive data? By becoming GDPR-compliant, our anonymisation platform AnonyMine, specialized in high-dimensional data such as clinical and microbiome, gives a second...

Belly bugs & Autism

Apr 21, 2020 | Health, Microbiome

For April’s Autism Awareness month, we wanted to return to the role of our gut bacteria in this neurodevelopmental...

Poster: Decrease diarrheal symptoms and modulation of intestinal microbiota by a new synbiotic in a murine model of food allergy

Jan 6, 2020 | Microbiome

This poster describes some of the microbiome analyses results obtained on a in vivo murine model of food allergy...

[POSTER] Fecal microbiota profile at diagnosis in the French IMODI cohort of breast cancer

Dec 11, 2019 | Microbiome, Pharma

Oumaïra Rahmouni (1), Cindy Pensec (1), Steven Roblin (1), Yao Amouzou (1), Amandine Charreton (2), Patricia Lapierre...

Poster: Decrease diarrheal symptoms and modulation of intestinal microbiota by a new synbiotic in a murine model of food allergy

by Administrateur Biofortis | Dec 7, 2018 | Microbiome

This poster describes some of the microbiome analyses results obtained on a in vivo murine model of food allergy designed for the ProtAlSafe project. ProtAlSafe is a research collaborative project selected during the 16th call...

Microbiome Hopes For Cancer Therapies

by Administrateur Biofortis | Nov 16, 2018 | Microbiome

DR SIDONIE N. LAVERGNE, COLLABORATIVE PARTNERSHIP MANAGER, BIOFORTIS MERIEUX NUTRISCIENCES Photo from Imactiv-3D (NOD-SCID MOUSE INTESTINE (10X) STAINED WITH PROPIDIUM IODIE AFTER BABB TRANSPARIZATION,VISUALIZED BY LIGHT SHEET MICROSCOPY (3D TOP IMAGE + AMIRA 2D...

Diet habits are important for your health, a matter of microbiome modulation

by Administrateur Biofortis | Oct 12, 2018 | Microbiome

Last October, 3-7th, the second "Nantes Food Forum" was organized in Nantes by 'Le Voyage à Nantes'. Five days to discuss and think about the "nutrition of tomorrow" in line with human health. Biofortis was a sponsor of the event and participated to the discussion on...

“House” Microbiota in a cold smoked salmon processing environment: A potential spoilage source

by Administrateur Biofortis | Sep 4, 2018 | Microbiome

Next september 4th, our NGS team will be present at FoodMicro 2018 in Berlin, Germany. After receiving two Awards from the IAFP (international Association for Food Protection) for the best poster presentation at the European symposium in Stockholm and at the MiBioGate...

Human Microbiome Therapeutics – Interview of Kristin Wanneberger (Ferring Pharmaceuticals)

by Administrateur Biofortis | Aug 14, 2018 | Microbiome, Pharma

Several kinds of Human Microbiome Therapeutics (HMTs) are emerging as excellent candidates for innovative health strategies, but some scientific and regulatory challenges remain. Despite no current market authorization, Fecal Microbiota Transplantation (FMT),...

Effects of pemetrexed chemotherapy on gut microbiota and digestive inflammation in Patient-Derived Tumor Xenograft (PDX) Models

by Administrateur Biofortis | Jul 18, 2018 | Health, Microbiome

C. PENSEC, T. CARTON, S. LEUILLET, D. GUENOT, IMODI Consortium, M. CAMPONE, H. BLOTTIERE, F. LE VACON Introduction Despite significant progress in anti-cancer treatment such as immunotherapy, chemotherapy remains a gold standard. Pemetrexed is a chemotherapeutic agent...